Results 1 to 10 of about 2,537 (171)
A bundle of the top 10 OPAT publications in 2024 [PDF]
Antimicrobial Stewardship & Healthcare EpidemiologyObjective: Outpatient parenteral antimicrobial therapy (OPAT) is a mainstay of clinical infectious diseases practice, and OPAT-related publications continue to be prominent in journals.
Lindsey M. Childs-Kean +9 more
doaj +4 more sources
Exploring the advancements of Australian OPAT
Therapeutic Advances in Infectious Disease, 2023 Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes.
Tony Lai +6 more
doaj +3 more sources
A Bundle of the Top 10 OPAT Publications in 2021
Open Forum Infectious Diseases, 2022 Abstract As outpatient parenteral antimicrobial therapy (OPAT) becomes more common, it may be difficult to stay current with recent related publications. A group of multidisciplinary OPAT clinicians reviewed and ranked all OPAT publications published in 2021.
Nipunie Rajapakse, Sara Keller
exaly +3 more sources
A Bundle of the Top 10 OPAT Publications in 2022
Open Forum Infectious Diseases, 2023 Abstract Outpatient parenteral antimicrobial therapy (OPAT) has become more common in clinical settings. Correspondingly, OPAT-related publications have also increased; the objective of this article was to summarize clinically meaningful OPAT-related publications in 2022.
Nipunie Rajapakse, Sara Keller
exaly +3 more sources
Management of outpatient parenteral antibiotic therapy: a United States-based multi-center survey [PDF]
Antimicrobial Stewardship & Healthcare EpidemiologyObjective: Outpatient parenteral antimicrobial therapy (OPAT) programs continue to evolve with increases in multidisciplinary teams, complex oral antibiotics, long-acting injectable antimicrobials, patients with substance use disorder (SUD) and ...
Laila M. Castellino +5 more
doaj +2 more sources
From sea to shining IV: the current state of OPAT in the United States
Therapeutic Advances in Infectious Disease, 2023 First described in the United States, outpatient parenteral antibiotic therapy (OPAT) has become an indispensable part of treating serious infections. The proportion of infectious disease (ID) physicians utilizing a formal OPAT program has increased in ...
Jeffrey Larnard, Simi Padival
exaly +2 more sources
Clinical Infection in Practice, 2022 Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with predictable course and anticipated response to therapy. However, there has been little consideration of OPAT for palliation as opposed to cure.
Evangelos Kritsotakis
exaly +3 more sources
Therapeutic Advances in Infectious Disease, 2023 Background: Select circumstances require outpatient parenteral antimicrobial therapy (OPAT). The potency of OPAT agents presents an increased risk of adverse events and unscheduled medical care. We analyzed these outcomes among OPAT recipients as part of
Michael D Evans +2 more
exaly +2 more sources
Clinical outcomes of teicoplanin use in the OPAT setting
International Journal of Antimicrobial Agents, 2020 Teicoplanin possesses several convenient properties for use in the delivery of outpatient parenteral antimicrobial therapy (OPAT) services. However, its use is not widespread and data on its efficacy in the OPAT setting are limited. Here we present a case series of patients undergoing OPAT care being treated by either teicoplanin-based (n = 107) or ...
Gabriele Pollara +2 more
exaly +4 more sources
Outpatient Parenteral Antimicrobial Therapy for Pseudomonas aeruginosa Infections: Effectiveness and Safety [PDF]
PharmaceuticsObjective: Given the increasing use of outpatient parenteral antimicrobial therapy (OPAT) and the clinical challenges posed by Pseudomonas aeruginosa infections, this study aimed to evaluate the effectiveness and safety of OPAT for the treatment of P ...
Paloma Suárez-Casillas +15 more
doaj +2 more sources